ValiRx plc (LON:VAL – Get Rating) shares crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 23.47 ($0.29) and traded as low as GBX 10.56 ($0.13). ValiRx shares last traded at GBX 10.75 ($0.13), with a volume of 587,308 shares trading hands.
ValiRx Price Performance
The stock’s 50-day moving average price is GBX 16.45 and its 200 day moving average price is GBX 23.47. The firm has a market cap of £6.99 million and a price-to-earnings ratio of -4.67. The company has a quick ratio of 11.13, a current ratio of 11.73 and a debt-to-equity ratio of 1.72.
ValiRx Company Profile
ValiRx plc, a biopharmaceutical company, engages in the development of oncology therapeutics and companion diagnostics in the United Kingdom. The company's lead drug candidates include VAL201, a small molecule that has completed Phase I/II trials for the treatment of prostate cancer and other hormone associated solid tumours comprising breast and ovarian cancer; and VAL401, a reformulation of anti-psychotic drug risperidone, which has completed Phase II clinical trial for the treatment of non-small cell lung cancer.
- Is Starbucks Shooting For The Moon?
- PayPal Continues To Struggle As Competition Increases
- Two High-Yield Deep-Values You Shouldn’t Ignore
- Proposed Tesla Stock Split Drives EV Market Higher
- Caterpillar Falls To Strong Support Near Bottom Of Range
Want More Great Investing Ideas?
- Bear Market Game Plan!
- The 10 Best Stocks to Own in 2022
- 7 Stocks to Buy and Hold Forever
- 3 Stocks to DOUBLE This Year
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.